Don Parsons leads process development activities for lipid nanoparticles for Moderna as a member of the Technical Development Leadership Team. He also coordinates CMC activities for Moderna’s early clinical development portfolio. He has over 25 years of experience in the pharmaceutical and biotechnology industry, leading process development and analytical development functions for both large and small molecules. He has a PhD in physical chemistry from the University of Wisconsin, and a BA in chemistry from Dartmouth College.